166 related articles for article (PubMed ID: 7756647)
1. The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor.
Vlot AJ; Koppelman SJ; van den Berg MH; Bouma BN; Sixma JJ
Blood; 1995 Jun; 85(11):3150-7. PubMed ID: 7756647
[TBL] [Abstract][Full Text] [Related]
2. Kinetics of factor VIII-von Willebrand factor association.
Vlot AJ; Koppelman SJ; Meijers JC; Dama C; van den Berg HM; Bouma BN; Sixma JJ; Willems GM
Blood; 1996 Mar; 87(5):1809-16. PubMed ID: 8634427
[TBL] [Abstract][Full Text] [Related]
3. Collagen-bound von Willebrand factor has reduced affinity for factor VIII.
Bendetowicz AV; Wise RJ; Gilbert GE
J Biol Chem; 1999 Apr; 274(18):12300-7. PubMed ID: 10212199
[TBL] [Abstract][Full Text] [Related]
4. Effect of multimerization of human and recombinant von Willebrand factor on platelet aggregation, binding to collagen and binding of coagulation factor VIII.
Fischer BE; Kramer G; Mitterer A; Grillberger L; Reiter M; Mundt W; Dorner F; Eibl J
Thromb Res; 1996 Oct; 84(1):55-66. PubMed ID: 8885147
[TBL] [Abstract][Full Text] [Related]
5. A new method measuring the interaction between von Willebrand factor and coagulation factor VIII.
Karlman M; Holmström M; Wiman B
Thromb Res; 2011 Jan; 127(1):47-50. PubMed ID: 21094987
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of von Willebrand disease type 2N: a simplified method for measurement of factor VIII binding to von Willebrand factor.
Miller CH; Kelley L; Green D
Am J Hematol; 1998 Aug; 58(4):311-8. PubMed ID: 9692396
[TBL] [Abstract][Full Text] [Related]
7. Factor VIII binds to von Willebrand factor via its Mr-80,000 light chain.
Hamer RJ; Koedam JA; Beeser-Visser NH; Bertina RM; Van Mourik JA; Sixma JJ
Eur J Biochem; 1987 Jul; 166(1):37-43. PubMed ID: 3109914
[TBL] [Abstract][Full Text] [Related]
8. Slowed release of thrombin-cleaved factor VIII from von Willebrand factor by a monoclonal and a human antibody is a novel mechanism for factor VIII inhibition.
Saenko EL; Shima M; Gilbert GE; Scandella D
J Biol Chem; 1996 Nov; 271(44):27424-31. PubMed ID: 8910322
[TBL] [Abstract][Full Text] [Related]
9. To serve and protect: The modulatory role of von Willebrand factor on factor VIII immunogenicity.
Hartholt RB; van Velzen AS; Peyron I; Ten Brinke A; Fijnvandraat K; Voorberg J
Blood Rev; 2017 Sep; 31(5):339-347. PubMed ID: 28716211
[TBL] [Abstract][Full Text] [Related]
10. New variant of von Willebrand disease with defective binding to factor VIII.
Nishino M; Girma JP; Rothschild C; Fressinaud E; Meyer D
Blood; 1989 Oct; 74(5):1591-9. PubMed ID: 2506947
[TBL] [Abstract][Full Text] [Related]
11. The effect of plasma von Willebrand factor on the binding of human factor VIII to thrombin-activated human platelets.
Nesheim M; Pittman DD; Giles AR; Fass DN; Wang JH; Slonosky D; Kaufman RJ
J Biol Chem; 1991 Sep; 266(27):17815-20. PubMed ID: 1917924
[TBL] [Abstract][Full Text] [Related]
12. The acidic region of the factor VIII light chain and the C2 domain together form the high affinity binding site for von willebrand factor.
Saenko EL; Scandella D
J Biol Chem; 1997 Jul; 272(29):18007-14. PubMed ID: 9218428
[TBL] [Abstract][Full Text] [Related]
13. A monoclonal antibody (NMC-VIII/10) to factor VIII light chain recognizing Glu1675-Glu1684 inhibits factor VIII binding to endogenous von Willebrand factor in human umbilical vein endothelial cells.
Shima M; Yoshioka A; Nakajima M; Nakai H; Fukui H
Br J Haematol; 1992 Aug; 81(4):533-8. PubMed ID: 1390241
[TBL] [Abstract][Full Text] [Related]
14. Alloantibody from a patient with severe von Willebrand disease inhibits von Willebrand factor-FVIII interaction.
Batlle J; Lourés E; Vila P; Hernández MC; Méndez JA; Torea J; Rendal E; Couselo MJ; Filgueira A; López Fernández MF
Ann Hematol; 1997 Sep; 75(3):111-5. PubMed ID: 9368480
[TBL] [Abstract][Full Text] [Related]
15. A role for the C2 domain of factor VIII in binding to von Willebrand factor.
Saenko EL; Shima M; Rajalakshmi KJ; Scandella D
J Biol Chem; 1994 Apr; 269(15):11601-5. PubMed ID: 7512568
[TBL] [Abstract][Full Text] [Related]
16. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates.
Lin Y; Yang X; Chevrier MC; Craven S; Barrowcliffe TW; Lemieux R; Ofosu FA
Haemophilia; 2004 Sep; 10(5):459-69. PubMed ID: 15357771
[TBL] [Abstract][Full Text] [Related]
17. Some factor VIII (FVIII) inhibitors recognise a FVIII epitope(s) that is present only on FVIII-vWF complexes.
Gilles JG; Lavend'homme R; Peerlinck K; Jacquemin MG; Hoylaerts M; Jorieux S; Mazurier C; Vermylen J; Saint-Remy JM
Thromb Haemost; 1999 Jul; 82(1):40-5. PubMed ID: 10456452
[TBL] [Abstract][Full Text] [Related]
18. Influence of von Willebrand factor on the reactivity of human factor VIII inhibitors with factor VIII.
Gensana M; Altisent C; Aznar JA; Casaña P; Hernández F; Jorquera JI; Magallón M; Massot M; Puig L
Haemophilia; 2001 Jul; 7(4):369-74. PubMed ID: 11442641
[TBL] [Abstract][Full Text] [Related]
19. Further evidence for recessive inheritance of von Willebrand disease with abnormal binding of von Willebrand factor to factor VIII.
López-Fernández MF; Blanco-López MJ; Castiñeira MP; Batlle J
Am J Hematol; 1992 May; 40(1):20-7. PubMed ID: 1566742
[TBL] [Abstract][Full Text] [Related]
20. Ultracentrifugal analysis of factor VIII and von Willebrand factor in therapeutic preparations.
Aronson DL; Chang P
Vox Sang; 1995; 69(1):8-13. PubMed ID: 7483501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
